title: Androgenizing effects of low-dose cyclosporin in male patients with early RA.
authors.forename: E J
authors.initials: EJ
authors.lastname: Giltay
authors.forename: B E
authors.initials: BE
authors.lastname: van den Borne
authors.forename: D
authors.initials: D
authors.lastname: van Schaardenburg
authors.forename: L J
authors.initials: LJ
authors.lastname: Gooren
authors.forename: C
authors.initials: C
authors.lastname: Popp-Snijders
authors.forename: M A
authors.initials: MA
authors.lastname: Blankenstein
authors.forename: B A
authors.initials: BA
authors.lastname: Dijkmans
mesh_terms: D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy*; D016572:Cyclosporine / Q000008:administration & dosage*; D013196:Dihydrotestosterone / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood*; D012738:Sex Hormone-Binding Globulin / Q000378:metabolism*
chemical_list: D018501:Antirheumatic Agents; D012738:Sex Hormone-Binding Globulin; D013196:Dihydrotestosterone; D016572:Cyclosporine; D017430:Prostate-Specific Antigen